相关实验视频

Updated: May 14, 2025

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Published on: December 23, 2010

在多发性髓瘤中,β-阿雷斯2作为预后指标和免疫调节因子

Parker Mathews¹, Xiaobei Wang¹, Jian Wu¹

¹Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.

|April 11, 2025

概括

在多发性骨髓瘤 (MM) 患者中,β-arrestin 2 (ARRB2) 升高,与生存率差和博特佐米布耐药性相关. ARRB2还会影响免疫检查点,这表明它在MM病原和免疫疗法耐药性方面发挥了作用.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

β-arrestin 2 (ARRB2) 是G蛋白合受体 (GPCR) 信号的关键调节者,影响细胞增殖,细胞亡和免疫反应.
ARRB2在多发性骨髓瘤 (MM) 发病过程中的特定作用仍然在很大程度上未被描述.
了解ARRB2在MM中的功能至关重要,特别是考虑到免疫疗法和免疫检查点抑制剂的兴起.

研究的目的:

调查新诊断的MM患者骨髓 (BM) 样本中ARRB2的表达水平.
将ARRB2表达与临床结果相关联,包括对蛋白酶体抑制剂治疗的反应和患者的存活率.
探索ARRB2在调节PD-1/PD-L1免疫检查点轴上的潜在作用.

主要方法:

在MM患者骨髓样本中对ARRB2表达的定量分析.
对ARRB2水平与临床参数 (治疗反应,无进展生存,总生存) 之间的相关性分析.
在体内 (ARRB2淘汰赛小鼠) 和体内 (siRNA淘汰赛) 研究评估ARRB2对免疫细胞中PD-1和PD-L1表达的影响.

主要成果:

与响应者相比,对博特佐米布耐药的MM患者的ARRB2表达显著更高.
在MM骨髓中ARRB2水平升高与较低的无进展和整体存活率相关.
ARRB2调制影响了T细胞上的PD-1表达和骨髓衍生抑制细胞上的PD-L1表达.

结论:

ARRB2在多发性骨髓瘤的发病过程中发挥着重要作用.
ARRB2表达与MM的不良预后和对蛋白酶体抑制剂治疗的耐药性有关.
通过调节瘤微环境中的免疫检查点,ARRB2可能会影响MM进展和免疫治疗反应.

关键词:

G蛋白结合受体 (GPCR) 是一种免疫检查点是免疫检查点.多发性骨髓瘤是多发性骨髓瘤的一种.总体存活率总体存活率没有进展的生存率.乙-阿雷斯二 (ARRB2) 是一种

更多相关视频

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

相关概念视频

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...